Osborne Clarke advises NeRRe Therapeutics on its £20 million Series B2 financing round
International law firm Osborne Clarke has advised NeRRe Therapeutics on its £20 million Series B2 financing round. The financing involved...
Published on
12/07/2021
Read time
1m